HTG Molecular Diagnostics competitors

Zippia score 3.8

HTG Molecular Diagnostics main competitors are Alder Biopharmaceuticals, Illumina, and Halozyme.

Competitor Summary. See how HTG Molecular Diagnostics compares to its main competitors:

Illumina has the most employees (7,800).
Employees at Alder Biopharmaceuticals earn more than most of the competitors, with an average yearly salary of $94,428.
The oldest company is Namsa, founded in 1967.

Work at HTG Molecular Diagnostics?

Share your experience

HTG Molecular Diagnostics vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
HTG Molecular Diagnostics	1997	3.8	Tucson, AZ	3	$6.4M	107
Illumina	1998	4.8	San Diego, CA	5	$4.4B	7,800
Lucigen	1998	4.4	Middleton, WI	4	$15.7M	20
Tocagen	2007	3.1	San Diego, CA	1	$1.0M	9
Protea Biosciences Group	2001	3.4	Morgantown, WV	1	$2.4M	35
Vical	1987	3.5	San Diego, CA	1	$12.4M	213
CyLex	1994	3.7	Columbia, MD	1	$3.1M	200
Alder Biopharmaceuticals	2004	4.4	Bothell, WA	2	$6.5M	202
Caliper Life Sciences	1995	4.5	Hopkinton, MA	1	$109.8M	200
Promega	1978	4.7	Madison, WI	2	$450.0M	1,601
Halozyme	1998	4.8	San Diego, CA	1	$1.0B	136
Adv Brain Monitoring	1997	3.5	Carlsbad, CA	1	$7.3M	49
MannKind	1991	4.7	Westlake Village, CA	2	$10.0M	233
Namsa	1967	4.2	Northwood, OH	5	$13.0M	142

Rate HTG Molecular Diagnostics' competitiveness in the market.

HTG Molecular Diagnostics salaries vs competitors

Among HTG Molecular Diagnostics competitors, employees at Alder Biopharmaceuticals earn the most with an average yearly salary of $94,428.

Compare HTG Molecular Diagnostics salaries vs competitors

Company	Average salary	Hourly salary	Salary score
HTG Molecular Diagnostics	$81,002	$38.94	-
Illumina	$94,044	$45.21	-
Lucigen	$50,032	$24.05	-
Tocagen	$46,634	$22.42	-
Protea Biosciences Group	$50,744	$24.40	-
Vical	$75,394	$36.25	-

Compare HTG Molecular Diagnostics job title salaries vs competitors

Company	Highest salary	Hourly salary
HTG Molecular Diagnostics	$85,104	$40.92
Halozyme	$106,340	$51.13
Illumina	$92,052	$44.26
Promega	$90,478	$43.50
Tocagen	$90,134	$43.33
Vical	$89,630	$43.09
Namsa	$89,293	$42.93
MannKind	$89,153	$42.86
Caliper Life Sciences	$87,880	$42.25
Adv Brain Monitoring	$86,363	$41.52
Protea Biosciences Group	$85,887	$41.29
CyLex	$85,811	$41.26
Lucigen	$85,231	$40.98
Alder Biopharmaceuticals	$83,507	$40.15

Do you work at HTG Molecular Diagnostics?

Does HTG Molecular Diagnostics effectively differentiate itself from competitors?

HTG Molecular Diagnostics jobs

HTG Molecular Diagnostics demographics vs competitors

Compare gender at HTG Molecular Diagnostics vs competitors

Job title	Male	Female
MannKind	53%	47%
Adv Brain Monitoring	57%	43%
Illumina	62%	38%
HTG Molecular Diagnostics	79%	21%

Male

Female

100%

75%

50%

25%

HTG Molecular Diagnostics

Illumina

Adv Brain Monitoring

MannKind

25%

50%

75%

100%

Compare race at HTG Molecular Diagnostics vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
HTG Molecular Diagnostics	56%	14%	5%	18%	6%	6.4
Illumina	46%	23%	7%	20%	5%	9.7
MannKind	57%	17%	10%	12%	4%	9.0
Adv Brain Monitoring	60%	18%	7%	10%	4%	6.8

HTG Molecular Diagnostics revenue vs competitors

HTG Molecular Diagnostics revenue is $6.4M. Among it's competitors, the company with the highest revenue is Illumina, $4.4B . The company with the lowest revenue is Tocagen, $1.0M.

HTG Molecular Diagnostics and similar companies CEOs

CEOBio

Paul Cleveland

Alder Biopharmaceuticals

Francis A. Desouza

Illumina

Francis Aurelio deSouza (born December 2, 1970) is an American entrepreneur and business executive. He is the president and chief executive officer (CEO) of Illumina and a member of the Board of Directors of The Walt Disney Company.

Michael E. Castagna

MannKind

Michael Castagna is a Board Member at MANNKIND CORP and Chief Executive Officer at MANNKIND CORP and is based in Westlake Village, California. He has worked as Vice President & Head, Biopharmaceuticals North America at Sandoz; Director, Endocrinology Marketing at Healthcare Business of Merck; and VP/Global Head:Commercial at Amgen. Michael attended Massachusetts College of Pharmacy and Health Sciences between 2012 and 2014, The Wharton School between 2003 and 2005, and Philadelphia College of Pharmacy & Science.

Marty Duvall

Tocagen

Vijay Samant

Vical

Vijay Samant is a Board Member at Brickell Biotech Inc. He has worked as President/CEO at Vical; Trustee at International Vaccine Institute (IVI); and VP:Vaccine/Exec Dir:Materials Mgmt at MERCK & CO., INC.. Vijay studied at Columbia University, University of Mumbai, and MIT Sloan.

Christophe Berthoux

Namsa

Christophe Berthoux is an Exec VP:Global Sales & Mktg/Chief Commercial Ofcr at CHARLES RIVER LABORATORIES, Member of the Board of Directors at Synexus, and Chairman at IMAGE ANALYSIS INC and is based in London, Greater London, United Kingdom. He has worked as CEO at Synexus, Chief Executive Officer at Synexus Clinical Research Ltd, and Gen Mgr:Clinical Svcs at CHARLES RIVER LABORATORIES.

Brad L Stewart

CyLex

Ralph Kauten

Lucigen

Experienced Board Member and leader with a demonstrated history of working in the biotechnology industry. Skilled in Business Planning, Biotechnology, Team Leadership, Management, and Risk Financing. Strong business development professional with a MBA focused in Accounting from University of Wisconsin-Madison.

Chris Berka

Adv Brain Monitoring

Stephen Turner

Protea Biosciences Group

Stephen Turner is Chief Executive Officer and Chairman of the Board, positions he has held since founding the company in July, 2001. From 1999 to 2001 he served as President and CEO of Quorum Sciences, Inc. From 1984 to 1997 he was President and CEO of Oncor, Inc. He founded Bethesda Research Laboratories, Inc. in 1975 and served as its Chairman and CEO from 1975 to 1983, at which time BRL became the molecular biology division of Life Technologies, Inc. Prior to commencing his career in biotechnology, Mr. Turner held the position of Director of Marketing for the Clinical Microbiology Division of Becton, Dickinson & Co. He received his B.A. from Stanford University in 1967. In 1994 he received the Ernst & Young Entrepreneur of the Year Award in Life Sciences for the Washington D.C. Region.